Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neurofibromatosis type 1.

K North1

  • 1Faculty of Medicine, University of Sydney, Australia. katryn@nch.edu.au

American Journal of Medical Genetics
|February 17, 2001
PubMed
Summary
This summary is machine-generated.

Neurofibromatosis 1 (NF1) causes cognitive deficits due to NF1 gene mutations affecting brain development. Animal models reveal similarities to human learning difficulties, aiding understanding of NF1 pathogenesis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

UNITY: A low-field magnetic resonance neuroimaging initiative to characterize neurodevelopment in low and middle-income settings.

Developmental cognitive neuroscience·2024
Same author

Development and preliminary evaluation of the Neurofibromatosis Type 1 Adult Quality of Life (NF1-AdQoL) questionnaire.

Clinical and experimental dermatology·2021
Same author

Monitoring of optic nerve function in Neurofibromatosis 2 children with optic nerve sheath meningiomas using multifocal visual evoked potentials.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia·2018
Same author

Nemaline myopathy with exclusively intranuclear rods and a novel mutation in ACTA1 (Q139H).

Neuropediatrics·2008
Same author

The self-concept of children and adolescents with neurofibromatosis type 1.

Child: care, health and development·2007
Same author

Evaluation of primary haemostasis in people with neurofibromatosis type 1.

Clinical and laboratory haematology·2004
Same journal

Abstracts for the Xth World Congress of Psychiatric Genetics. Brussels, Belgium, 9-13 October 2002.

American journal of medical genetics·2003
Same journal

Defects of blastogenesis.

American journal of medical genetics·2002
Same journal

Malformations of the craniofacial region: evolutionary, embryonic, genetic, and clinical perspectives.

American journal of medical genetics·2002
Same journal

Limb anomalies: Developmental and evolutionary aspects.

American journal of medical genetics·2002
Same journal

Molecular etiology of gut malformations and diseases.

American journal of medical genetics·2002
Same journal

Status of the human malformation map: 2002.

American journal of medical genetics·2002
See all related articles

Area of Science:

  • Neurogenetics
  • Developmental Biology
  • Clinical Neurology

Background:

  • Neurofibromatosis 1 (NF1) is a common genetic disorder affecting the nervous system.
  • NF1 is linked to cognitive deficits and learning difficulties in children.
  • The role of the NF1 gene in non-tumor manifestations is not fully understood.

Purpose of the Study:

  • To review the function of the NF1 gene.
  • To describe cognitive deficits in NF1.
  • To correlate findings from human studies and animal models for NF1 pathogenesis.

Main Methods:

  • Literature review of NF1 gene function, cognitive deficits, and neuroradiological findings.
  • Analysis of animal models for NF1, focusing on behavioral abnormalities.
  • Synthesis of pathological and neuropsychological data.

Related Experiment Videos

Main Results:

  • The NF1 protein, neurofibromin, is crucial for early brain development.
  • NF1 mouse models exhibit cognitive phenotypes similar to human patients.
  • Correlations between imaging, pathology, and behavior offer insights into NF1's neurological impact.

Conclusions:

  • NF1 gene mutations impact neurodevelopment, leading to cognitive impairments.
  • Understanding neurofibromin's role is key to addressing non-tumor NF1 complications.
  • Animal models are valuable tools for investigating NF1 pathogenesis and potential treatments.